Sami-Sabinsa Group bags Best Patent Portfolio award

CII Industrial Intellectual Property (IP) Award is the recognition and celebration of Indian enterprises that have embraced IP generation and protection to fuel their economic growth

Sami-Sabinsa Group, a leader in health science, was honored with the Best Patent Portfolio award in SME (Life Science and Pharma) and Best Trademark Portfolio in SME (Life Science and Pharma) at CII Industrial Intellectual Property Awards held recently.

“These awards are a recognition of the pioneering work accomplished in the IP domain by the Sami-Sabinsa team,” said Dr Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group. “With research at the core of everything we do, Sami-Sabinsa continues to develop innovative, patented nutraceutical and cosmeceutical products for our clients globally.”

Founded in 1988 by Dr Muhammed Majeed, Sami-Sabinsa Group has a sizeable patent portfolio comprising over 277 granted patents and 300 pending patent applications worldwide. 

CII Industrial Intellectual Property (IP) Award is the recognition and celebration of Indian enterprises that have embraced IP generation and protection to fuel their economic growth and lend a hand towards the country’s economic progress.

The purpose of these awards is to encourage organizations to foster a culture of IP and its commercialization, bring the achievements of enterprises in the public domain, set up linkages with academic and research institutions in India and abroad, inform the government about IP-driven enterprises and engage such enterprises in policy-making exercises.

Sami-Sabinsa Group is a leading producer of nutraceuticals, cosmeceuticals, standardized herbal extracts, fine chemicals, specialty chemicals, and probiotics.